# Influence of Chronotype and Theobromine on the 24-h Variation in Peak Expiratory Flow Rate in Healthy Adults

**Authors:** Anika Köhlmoos, Manuela Dittmar

PMC · DOI: 10.5334/jcr.242 · Journal of Circadian Rhythms · 2025-04-03

## TL;DR

This study shows that morningness-eveningness preference and theobromine from chocolate affect how lung function varies over 24 hours in healthy adults.

## Contribution

The study reveals that theobromine's effect on lung function varies by chronotype, suggesting personalized treatment timing for respiratory conditions.

## Key findings

- Both early and late chronotypes showed significant 24-hour variation in peak expiratory flow rate.
- Late chronotypes responded differently to theobromine, with increased morning lung function and reduced evening decline.
- Maximum peak expiratory flow occurred earlier in early chronotypes and correlated with sleep timing.

## Abstract

The influence of morningness-eveningness preference and dietary components on the circadian variation in peak expiratory flow (PEF), an established criterion for pulmonary function, is not fully understood. This study aimed to investigate (a) how the chronotype influences the 24-h variation in PEF and (b) whether the bronchodilator theobromine affects this variation differently in different chronotypes. Ninety-seven healthy non-smoking females (54 early chronotypes, ET; 43 late chronotypes, LT; 18–35 years) recorded their PEF over 24 hours at 4-h intervals (08:00/12:00/16:00/20:00/24:00/04:00/08:00 h). In a subgroup (26 ET, 18 LT), the effect of 48 mg theobromine (40 g dark chocolate) on PEF was compared on three consecutive 24-h days with no administration, morning administration and evening administration of theobromine. Repeated measures ANOVA tested for 24-h variation in PEF. Both chronotypes displayed significant 24-h variation in PEF (P < 0.0001) explaining 36% (ET) and 31% (LT) of variance of PEF. The time of maximum PEF was three hours earlier in ET than in LT (P = 0.003) and correlated negatively with chronotype scores (P = 0.001) and positively with bedtimes (awakening time: P < 0.001; sleep-onset time: P = 0.012). The chronotypes showed no differences in 24-h mean and amplitude % mean for PEF. Administration of theobromine strengthened the morning increase (P = 0.004) and weakened the evening decrease (P = 0.063) of PEF in LT, but had no effect in ET. The differences found between chronotypes in timing of maximum PEF and responsiveness to the bronchodilator theobromine might have clinical relevance. Therapy for respiratory diseases should consider the chronotype of patients for drug timing and dosage.

## Linked entities

- **Chemicals:** theobromine (PubChem CID 5429)

## Full-text entities

- **Diseases:** respiratory diseases (MESH:D012140)
- **Chemicals:** Theobromine (MESH:D013805)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11967464/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11967464/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC11967464/full.md

---
Source: https://tomesphere.com/paper/PMC11967464